The global portable ultrasound bladder scanner market size is anticipated to reach USD 353.8 million by 2030, registering a CAGR of 3.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include increasing occurrences of urological disorders, advancements in technology, rising acceptance of point-of-care diagnostic devices, and heightened awareness and education.
The portable ultrasound bladder scanner is an efficient device owing to its versatility, convenience, and accuracy in diagnosing bladder-related issues. In contrast to traditional methods, which frequently involve invasive procedures or prolonged processes, this compact device offers rapid and non-invasive assessments of bladder volume and residual urine.
Technological advancements such as real-time volume calculations, automated bladder recognition, and integration of AI with these devices is expected to boost market growth. For instance, in January 2024, Clarius obtained FDA approval for its Clarius Bladder AI, a non-invasive tool that measures bladder volume within seconds. This innovative solution is currently available in the U.S., compatible with the Clarius PAL HD3, Clarius PA HD3, and the Clarius C3 HD3 wireless handheld ultrasound scanners .
The increasing incidence of urological conditions like bladder cancer, urinary incontinence and many others is anticipated to drive substantial demand for portable ultrasound bladder scanners. For instance, according to the International Agency for Research on Cancer, in 2022, there were about 614,298 cases of bladder cancer globally which is further expected to rise to 1,950,315 by 2027. With aging populations, lifestyle shifts, and heightened awareness leading to earlier detection, these conditions are becoming more prevalent. Consequently, there's a growing necessity for efficient diagnostic tools capable of accurately assessing bladder health.
Based on product, the 2D segment dominated the market with the largest share of 61.1% in 2023. Its ease of use makes it well-suited for regular exams and quick evaluations
The 3D segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to various factors, including advancements in technology and growing preferences in clinical practice
The hospital segment dominated the market with the largest share in 2023 and is expected to grow at the fastest CAGR over the forecast period. Hospitals remain the primary option for patients seeking medical care, particularly for conditions like urinary tract infections (UTIs) and urinary incontinence, which require frequent bladder assessments
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America